| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 3,139 | 4,626 | 2,986 | 3,203 | | Selling General and Administrative | 1,372 | 1,789 | 1,874 | 3,439 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,511) | (6,415) | (4,860) | (6,642) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 137 | (126) | 26 | 100 | | Earnings Before Interest And Taxes | (4,374) | (6,541) | (4,834) | (6,542) | | Interest Expense | 482 | 124 |
-
|
-
| | Income Before Tax | (4,856) | (6,665) | (4,834) | (6,542) | | Income Tax Expense | 550 |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,406) | (6,665) | (4,834) | (6,542) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,406) | (6,665) | (4,834) | (6,542) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,406) | ($6,665) | ($4,834) | ($6,542) |
|
0.03% Nasdaq 0.00%
Income Statement
